2026 ICD-10-CM Diagnosis Code T36.1X2APoisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, initial encounter

ICD-10-CM CodesS00–T88T36-T50T36

ICD-10-CM T36.1X2A
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

T36.1X2A is a billable ICD-10-CM diagnosis code for poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, initial encounter. The 7th character A marks it as an initial encounter code, used while the patient is receiving active treatment. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 917 through 918. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under External cause codes: intent of injury, self-harm; External cause codes: poisoning by drug; and Poisoning by drugs, initial encounter.

Code Identity

ICD-10-CM Code
T36.1X2A
Billable Status
Yes — Valid for Submission
Code Describes
Poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, initial encounter
Short Description
Poisn by cephalospor/oth beta-lactm antibiot, slf-hrm, init
Parent Code
Poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT36Poisoning by, adverse effect of and underdosing of systemic antibiotics
This CodeT36.1X2APoisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, initial encounter

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Cefaclor overdose
  • Cefaclor poisoning
  • Cefadroxil overdose
  • Cefadroxil poisoning
  • Cefixime overdose
  • Cefixime poisoning
  • Cefodizime overdose
  • Cefodizime poisoning
  • Cefotaxime overdose
  • Cefotaxime poisoning
  • Cefpirome overdose
  • Cefpirome poisoning
  • Cefpodoxime overdose
  • Cefpodoxime poisoning
  • Cefsulodin overdose
  • Cefsulodin poisoning
  • Ceftazidime overdose
  • Ceftazidime poisoning
  • Ceftibuten overdose
  • Ceftibuten poisoning
  • Ceftizoxime overdose
  • Ceftizoxime poisoning
  • Ceftriaxone overdose
  • Ceftriaxone poisoning
  • Cefuroxime overdose
  • Cefuroxime poisoning
  • Cephalexin overdose
  • Cephalothin overdose
  • Cephamandole overdose
  • Cephamandole poisoning
  • Cephazolin overdose
  • Cephazolin poisoning
  • Cephradine overdose
  • Cephradine poisoning
  • Fourth generation cephalosporin overdose
  • Fourth generation cephalosporin poisoning
  • Intentional cefaclor overdose
  • Intentional cefaclor poisoning
  • Intentional cefadroxil overdose
  • Intentional cefadroxil poisoning
  • Intentional cefixime overdose
  • Intentional cefixime poisoning
  • Intentional cefodizime overdose
  • Intentional cefodizime poisoning
  • Intentional cefotaxime overdose
  • Intentional cefotaxime poisoning
  • Intentional cefpirome overdose
  • Intentional cefpirome poisoning
  • Intentional cefpodoxime overdose
  • Intentional cefpodoxime poisoning
  • Intentional cefsulodin overdose
  • Intentional cefsulodin poisoning
  • Intentional ceftazidime overdose
  • Intentional ceftazidime poisoning
  • Intentional ceftibuten overdose
  • Intentional ceftibuten poisoning
  • Intentional ceftizoxime overdose
  • Intentional ceftizoxime poisoning
  • Intentional ceftriaxone overdose
  • Intentional ceftriaxone poisoning
  • Intentional cefuroxime overdose
  • Intentional cefuroxime poisoning
  • Intentional cephalexin overdose
  • Intentional cephalexin poisoning
  • Intentional cephaloridine poisoning
  • Intentional cephalothin overdose
  • Intentional cephalothin poisoning
  • Intentional cephamandole overdose
  • Intentional cephamandole poisoning
  • Intentional cephazolin overdose
  • Intentional cephazolin poisoning
  • Intentional cephradine overdose
  • Intentional cephradine poisoning
  • Intentional latamoxef overdose
  • Intentional latamoxef poisoning
  • Latamoxef overdose
  • Latamoxef poisoning
  • Poisoning by cephalexin
  • Poisoning by cephaloridine
  • Poisoning by cephalothin
  • Second generation cephalosporin overdose

Coding GuidelinesGuidance

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined). If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of systemic antibiotics (T36). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR EXT021
External cause codes: intent of injury, self-harm
Default principal diagnosis: inpatient No · outpatient No
CCSR EXT014
External cause codes: poisoning by drug
Default principal diagnosis: inpatient No · outpatient No
CCSR INJ022
Poisoning by drugs, initial encounter
Default principal diagnosis: inpatient No · outpatient No
CCSR MBD012
Suicidal ideation/attempt/intentional self-harm
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Aztreonam

    a monocyclic beta-lactam antibiotic originally isolated from chromobacterium violaceum. it is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. it may cause a superinfection with gram-positive organisms.
  • Cefaclor

    semisynthetic, broad-spectrum antibiotic derivative of cephalexin.
  • Cefadroxil

    long-acting, broad-spectrum, water-soluble, cephalexin derivative.
  • Cefamandole

    semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. it is used also as the nafate.
  • Cefatrizine

    orally active semisynthetic cephalosporin antibiotic with broad-spectrum activity.
  • Cefazolin

    a semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. it attains high serum levels and is excreted quickly via the urine.
  • Cefixime

    a third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
  • Cefmenoxime

    a cephalosporin antibiotic that is administered intravenously or intramuscularly. it is active against most common gram-positive and gram-negative microorganisms, is a potent inhibitor of enterobacteriaceae, and is highly resistant to hydrolysis by beta-lactamases. the drug has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.
  • Cefmetazole

    a semisynthetic cephamycin antibiotic with a broad spectrum of activity against both gram-positive and gram-negative microorganisms. it has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.
  • Cefonicid

    a second-generation cephalosporin administered intravenously or intramuscularly. its bactericidal action results from inhibition of cell wall synthesis. it is used for urinary tract infections, lower respiratory tract infections, and soft tissue and bone infections.
  • Cefoperazone

    semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. it may be used to treat pseudomonas infections.
  • Cefotaxime

    semisynthetic broad-spectrum cephalosporin.
  • Cefotetan

    a semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. the drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms.
  • Cefotiam

    one of the cephalosporins that has a broad spectrum of activity against both gram-positive and gram-negative microorganisms.
  • Cefoxitin

    a semisynthetic cephamycin antibiotic resistant to beta-lactamase.
  • Cefsulodin

    a pyridinium-substituted semisynthetic, broad-spectrum antibacterial used especially for pseudomonas infections in debilitated patients.
  • Ceftazidime

    semisynthetic, broad-spectrum antibacterial derived from cephaloridine and used especially for pseudomonas and other gram-negative infections in debilitated patients.
  • Ceftizoxime

    a semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. the drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. it has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.
  • Ceftriaxone

    a broad-spectrum cephalosporin antibiotic and cefotaxime derivative with a very long half-life and high penetrability to meninges, eyes and inner ears.
  • Cefuroxime

    broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. it has been proposed for infections with gram-negative and gram-positive organisms, gonorrhea, and haemophilus.
  • Cephalexin

    a semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of cephaloridine or cephalothin, but somewhat less potent. it is effective against both gram-positive and gram-negative organisms.
  • Cephalosporinase

    a cephalosporin antibiotic.
  • Cephaloglycin

    a cephalorsporin antibiotic.
  • Cephaloridine

    a cephalosporin antibiotic.
  • Cephalosporins

    a group of broad-spectrum antibiotics first isolated from the mediterranean fungus acremonium. they contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.
  • First Generation Cephalosporins

    cephalosporin agents with excellent coverage against gram-positive cocci, such as staphylococcus and streptococcus. they have some activity against the gram-negative bacteria, but in general, gram-negative activity is decreased compared to 2nd, 3rd, and 4th generation cephalosporins.
  • Second Generation Cephalosporins

    agents with less activity against gram-positive cocci than first generation cephalosporins but have increased activity against gram-negative bacilli.
  • Third Generation Cephalosporins

    agents that are structurally similar to other cephalosporins but have a broader spectrum of activity against bacteria than the first and second generation cephalosporins. these agents cover more resistant streptococcus, staphylococcus, gram-positive anaerobes, and more resistant strains of haemophilus, neisseria, proteus, escherichia coli, and klebsiella (hnpek).
  • Cephalothin

    a cephalosporin antibiotic.
  • Cephradine

    a semi-synthetic cephalosporin antibiotic.
  • Clavulanic Acid

    a beta-lactam antibiotic produced by the actinobacterium streptomyces clavuligerus. it is a suicide inhibitor of bacterial beta-lactamase enzymes. administered alone, it has only weak antibacterial activity against most organisms, but given in combination with other beta-lactam antibiotics it prevents antibiotic inactivation by microbial lactamase.
  • Clavulanic Acids

    acids, salts, and derivatives of clavulanic acid (c8h9o5n). they consist of those beta-lactam compounds that differ from penicillin in having the sulfur of the thiazolidine ring replaced by an oxygen. they have limited antibacterial action, but block bacterial beta-lactamase irreversibly, so that similar antibiotics are not broken down by the bacterial enzymes and therefore can exert their antibacterial effects.

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect
Under­dosing
AztreonamT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefacetrileT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefaclorT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefadroxilT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefalexinT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefaloglycinT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefaloridineT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefalosporinsT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefalotinT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefamandoleT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
Cefamycin antibioticT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefapirinT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefatrizineT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefazedoneT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefazolinT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefbuperazoneT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefetametT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefiximeT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefmenoximeT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefmetazoleT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefminoxT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefonicidT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefoperazoneT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CeforanideT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefotaximeT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefotetanT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefotiamT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefoxitinT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefpimizoleT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefpiramideT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefradineT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefroxadineT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefsulodinT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CeftazidimeT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefteramT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CeftezoleT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CeftizoximeT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CeftriaxoneT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefuroximeT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CefuzonamT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CephalexinT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CephaloglycinT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CephaloridineT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CephalosporinsT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
Cephalosporins::N (adicillin)T36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CephalothinT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CephalotinT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
CephradineT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
Clavulanic acidT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
FlomoxefT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6
LatamoxefT36.1X1T36.1X2T36.1X3T36.1X4T36.1X5T36.1X6

Patient EducationClinical

Antibiotics

Antibiotics are medicines that fight bacterial infections in people and animals. They work by killing the bacteria or by making it hard for the bacteria to grow and multiply.

The full article covers:

  • What are antibiotics?
  • What do antibiotics treat?
  • Do antibiotics treat viral infections?
  • What are the side effects of antibiotics?
  • Why is it important to take antibiotics only when they're needed?
  • How do I use antibiotics correctly?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T36.1X2A to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
960.5 Pois-cephalosporin group
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E950.4 Poison-drug/medicin NEC
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About T36.1X2AOverview

Is T36.1X2A a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, initial encounter on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What does the 7th character A in T36.1X2A mean?

The final character A marks the initial encounter: use it while the patient is receiving active treatment for poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, such as an emergency visit or first evaluation.

What MS-DRG does T36.1X2A group to?

When poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, initial encounter is the principal diagnosis on an inpatient stay, it groups to MS-DRG 917, 918, with relative weights from 0.8571 to 1.5684 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of T36.1X2A?

Under the General Equivalence Mappings, poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, initial encounter converts to ICD-9-CM 960.5 (pois-cephalosporin group) and E950.4 (poison-drug/medicin NEC). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.